Poliomyelitis: present epidemiological situation and vaccination problems.
作者信息
Mensi C, Pregliasco F
机构信息
Istituto di Virologia, Università di Milano, Milan, Italy.
出版信息
Clin Diagn Lab Immunol. 1998 May;5(3):278-80. doi: 10.1128/CDLI.5.3.278-280.1998.
Abstract
摘要
相似文献
1
Poliomyelitis: present epidemiological situation and vaccination problems.脊髓灰质炎：当前的流行病学状况及疫苗接种问题
Clin Diagn Lab Immunol. 1998 May;5(3):278-80. doi: 10.1128/CDLI.5.3.278-280.1998.
2
Poliomyelitis vaccines in Belgium: 20 years of experience.
Dev Biol Stand. 1979;43:187-93.
3
Epidemiology of poliomyelitis--options and update.脊髓灰质炎流行病学——选项与更新
Vaccine. 2008 Oct 23;26(45):5767-73. doi: 10.1016/j.vaccine.2008.07.101. Epub 2008 Aug 26.
4
5
Poliovirus vaccine and vaccine-derived polioviruses.脊髓灰质炎疫苗和疫苗衍生脊髓灰质炎病毒
N Engl J Med. 2010 Nov 4;363(19):1870; author reply 1870-1. doi: 10.1056/NEJMc1009551.
6
When can we stop using oral poliovirus vaccine?我们什么时候可以停止使用口服脊髓灰质炎疫苗？
J Infect Dis. 2005 Dec 15;192(12):2033-5. doi: 10.1086/498171. Epub 2005 Nov 8.
7
Control of poliomyelitis: a continuing paradox.脊髓灰质炎的防控：一个持续存在的悖论。
J Infect Dis. 1982 Oct;146(4):540-51. doi: 10.1093/infdis/146.4.540.
8
[Immunoprophylaxis of poliomyelitis in Ukraine with the use of inactivated vaccine].[乌克兰使用灭活疫苗进行脊髓灰质炎免疫预防]
Zh Mikrobiol Epidemiol Immunobiol. 2005 Jan-Feb(1):49-53.
9
Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.用灭活脊髓灰质炎病毒疫苗进行初次免疫后对口服脊髓灰质炎病毒疫苗的中和抗体反应。
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):815-6. doi: 10.1007/s100960050198.
10
Poliovirus vaccine and vaccine-derived polioviruses.脊髓灰质炎疫苗和疫苗衍生脊髓灰质炎病毒
N Engl J Med. 2010 Nov 4;363(19):1870; author reply 1870-1. doi: 10.1056/NEJMc1009551.
引用本文的文献
1
Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.鼻腔内给予 IL-1α 可发挥最大佐剂活性，需要佐剂反应性 CD11c(+)细胞，且与佐剂诱导的体内细胞因子产生无关。
J Immunol. 2012 Mar 15;188(6):2834-46. doi: 10.4049/jimmunol.1100254. Epub 2012 Feb 15.
本文引用的文献
1
Antipoliomyelitis immunity status in a cohort of young men drafted into military service, residing in the suburban Milan area.
Eur J Epidemiol. 1997 Sep;13(6):725-7. doi: 10.1023/a:1007331900645.
2
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防：采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
3
Recommended childhood immunization schedule--United States, 1997.1997年美国推荐的儿童免疫接种程序表
MMWR Morb Mortal Wkly Rep. 1997 Jan 17;46(2):35-40.
4
A seroepidemiologic survey of immunity against poliomyelitis in a group of HIV positive and HIV negative drug addicts.
Eur J Epidemiol. 1995 Dec;11(6):693-5. doi: 10.1007/BF01720304.
5
6
Immune response to a booster dose of enhanced potency inactivated polio vaccine administered in association with HBV vaccine in adolescents.
Vaccine. 1996 Mar;14(4):267-9. doi: 10.1016/0264-410x(95)00209-j.
7
Expanded programme on immunization. Progress towards the global eradication of poliomyelitis, 1995.扩大免疫规划。1995年全球根除脊髓灰质炎的进展情况。
Wkly Epidemiol Rec. 1996 Jun 21;71(25):189-94.
8
[Poliomyelitis: vaccination is still important].[脊髓灰质炎：疫苗接种仍然很重要]
Ann Ig. 1994 Jul-Dec;6(4-6):675-84.
9
Mass vaccination campaigns to control the 1991-1992 poliomyelitis outbreak.
Wkly Epidemiol Rec. 1993 Jul 23;68(30):222-3.
10
Immunity to polioviruses and tetanus after bone marrow transplantation in children.
Pediatr Hematol Oncol. 1994 May-Jun;11(3):331-6. doi: 10.3109/08880019409141677.
Zotero 插件